Mapping DNA and RNA changes in Acute Myeloid Leukemia at the single-cell level
High-throughput single-cell joint RNA and DNA methylation mapping of Acute Myeloid Leukemia
This study is looking at how changes in DNA and gene activity affect Acute Myeloid Leukemia (AML), using a new technique to examine individual cells, which could help doctors find better ways to diagnose and treat the disease just for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11062605 on NIH RePORTER |
What this research studies
This research focuses on understanding how changes in DNA methylation and gene expression contribute to Acute Myeloid Leukemia (AML). By developing a new method called SHARE-ME-seq, the team aims to analyze individual cells to uncover the complex interactions between DNA methylation and gene regulation. This approach will help identify specific patterns that are characteristic of AML, potentially leading to better diagnostic and treatment strategies. Patients may benefit from insights gained about their disease at a cellular level, which could inform personalized treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Acute Myeloid Leukemia who are seeking advanced treatment options.
Not a fit: Patients with other types of leukemia or those without a diagnosis of Acute Myeloid Leukemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted treatments for patients with Acute Myeloid Leukemia.
How similar studies have performed: Previous research has shown promise in using single-cell technologies to understand cancer, suggesting that this approach could yield valuable insights.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Ma, Sai — Icahn School of Medicine at Mount Sinai
- Study coordinator: Ma, Sai
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.